REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/06/2026
Voltar para busca
Dado oficial do USPTO
HEALX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
09/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
06/01/2020
Data de registro
08/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/06/2021
Última transação
09/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
GB
Examinador
BLANE, SUZANNE
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Healx Limited
Representantes
Jesse A. Hirshman The Webb Law Firm
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical drugs; drugs for medical purposes; medicines for human purposes; all of the goods for use in treating rare diseases
Classe 42
Scientific and technological services and research and design relating theretodrug discovery services using artificial intelligence; industrial analysis and research services; design and development of computer hardware and software; biological research; research and development of new products for others; pharmaceutical drug development services; drug discovery services; data and literature mining servicesthe development of automated Natural Language Processing software; software design; computer software design; consultancy pertaining to pharmacology; consultancy pertaining to pharmaceuticals; maintaining databases pertaining to rare diseases; medical treatment for rare diseases; scientific research for medical purposes in the field of rare diseases; research and development services in the field of artificial intelligence; computer software development; computer software development for use in the healthcare field; computer software development for use in the field of rare diseases; design and development of computer software for use in the healthcare field; design and development of computer software for use in the field of rare diseases
Classe 44
Medical services; health consultancy; healthcare services; medical treatment services for rare diseases; healthcare advisory services; collation of information in the healthcare sectorthe development and collation of rare disease knowledge data sets; pharmaceutical advice; medical clinic services; medical advice for individuals with rare diseases; advisory services relating to rare diseases; advisory services relating to treatment of rare diseases; provision of medicine in the field of rare diseasesdeveloping treatments for unmet medical needs
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/10/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/09/2021
FIMP
FINAL DISPOSITION PROCESSED
29/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/03/2021
PUBO
PUBLISHED FOR OPPOSITION
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2021
ALIE
ASSIGNED TO LIE
21/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/09/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/09/2020
RFNT
REFUSAL PROCESSED BY IB
01/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/04/2020
RFRR
REFUSAL PROCESSED BY MPU
16/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/04/2020
CNRT
NON-FINAL ACTION WRITTEN
31/03/2020
DOCK
ASSIGNED TO EXAMINER
25/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEALX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.